Forte Biosciences Inc (FBRX) is a Healthcare · Biotechnology company listed on NASDAQ. Price $76.99 (+0.03%), Market cap $0.51B, 52-week low–high $7.11 ~ $35.53.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Financial statements, price targets, institutional (13F) holdings and related news for Forte Biosciences Inc are updated in real time on BlackAll Trade.
Forte Biosciences Inc trades at $76.99 (+0.03%). Real-time quotes and charts are available on BlackAll Trade.
Forte Biosciences Inc has a market cap of about $0.51B.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody th